Risk of differential cancer types over age in families with Li-Fraumeni syndrome: a validation study using multi-center cohorts
Author:
Shin Seung Jun,Dodd Elissa,Peng Gang,Bojadzieva Jasmina,Chen Jingxiao,Amos Chris,Mai Phuong L.,Savage Sharon A.,Ballinger Mandy L.,Thomas David M.,Yuan Ying,Strong Louise C.,Wang Wenyi
Abstract
ABSTRACTLi-Fraumeni syndrome (LFS) is a rare hereditary cancer syndrome associated with an autosomal dominant mutation inheritance in the TP53 tumor suppressor gene and a wide spectrum of cancer diagnoses. An accurate estimation of the penetrance of different cancer types in LFS is crucial to improve the clinical characterization and management of high-risk individuals of LFS. Our competing risk-based statistical model incorporates the pedigree structure efficiently into the penetrance estimation and corrects for the ascertainment bias. A set of TP53 penetrance for three cancer types (breast, BR/sarcoma, SA/others, OT) involved in LFS is then estimated from 186 pediatric-sarcoma families collected at MD Anderson Cancer Center. The penetrance was then validated on a mixed cohort of clinically ascertained families with cancer (total number of families=668). The age-dependent onset probability distributions of specific cancer types are different. For breast cancer, the TP53 penetrance goes up at an earlier age than the reported BRCA1/2 penetrance. We validated the prediction performance of the penetrance estimates via two independent cohorts combined (BR=85, SA=540, OT=158). We obtained areas under the ROC curves (AUCs) of 0.92 (BR), 0.75 (SA), and 0.81 (OT). Our R package, LFSPRO, provides risk estimates for the diagnosis of breast cancer, sarcoma, other cancers or death before cancer diagnosis in future.SignificanceCancer-specific penetrance can facilitate clinical characterization of LFS and will contribute to the management of families at high risk of LFS.
Publisher
Cold Spring Harbor Laboratory
Reference31 articles.
1. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome;J. Natl. Cancer Inst,1969
2. Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms
3. Cancer in survivors of childhood soft tissue sarcoma and their relatives;J. Natl. Cancer Inst,1987
4. Prevalence and Diversity of Constitutional Mutations in the p53 Gene among 21 Li-Fraumeni Families;Cancer Res,1994
5. Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53;Br. J. Cancer,1994